ASCO 2022 Conference Coverage

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

ASCO 2022 Conference Coverage

Breast
Lung
GI
GU
Skin
GYN
Head & Neck
Leukemia
Lymphoma
Myeloma
MDS and MPN
Sarcoma

Playback speed

10 seconds

ASCO 2022 on Clinical & PROs in a Phase III, Randomized, Open-Label Study Evaluating Axicabtagene Ciloleucel vs. SoC Therapy in Elderly Pts With R/R LBCL

By ASCO 2022 Conference Coverage FEATURING Jason Westin

58 views

June 9, 2022

Comments 0

Communicating the Risk of Recurrence for Patients With HR+, HER2- Ea…

Feat. J. O’Shaughnessy

Mechanisms of Resistance in Locally Advanced or Metastatic EGFR+ NSC…

Feat. J. Heymach, M. Das

Lymphoma

2022 ASCO Annual Meeting "The Effects of AVM0703 Mobilization of End…

ASCO 2022 Conference Coverage

J. Dalpez

118 views

Lecture Summary - ASCO 2022 on the Phase 2 KEYNOTE-C11 Study: Sequen…

ASCO 2022 Conference Coverage

J. Winter

42 views

ASCO 2022 on the Phase 2 KEYNOTE-C11 Study: Sequential Pembro & Chem…

ASCO 2022 Conference Coverage

J. Winter

13 views

Lecture Summary - ASCO 2022 on the Phase III frontMIND Study: Tafasi…

ASCO 2022 Conference Coverage

U. Vitolo

42 views

ASCO 2022 on the Phase III frontMIND Study: Tafasitamab + Lenalidomi…

ASCO 2022 Conference Coverage

U. Vitolo

23 views

ASCO 2022 on the Analysis of Peripheral Neuropathy in 1L DLBCL Using…

ASCO 2022 Conference Coverage

M. Trneny

23 views

ASCO 2022 ADCs and CARs: Racing to Cure Aggresive Lymphoma

ASCO 2022 Conference Coverage

K. Patel

85 views

ASCO 2022 on the Predictive Value of TGFβ1/TGFBR2 Ratio for Evaluati…

ASCO 2022 Conference Coverage

V. Bandovkina

106 views

ASCO 2022 Expert Discussion: Current Treatment Approaches in Hemophi…

ASCO 2022 Conference Coverage

J. Bussel, C. Mcguinn

55 views

Lecture Summary - ASCO 2022 Treatment Patterns and Real-World Effect…

ASCO 2022 Conference Coverage

M. Di

8 views

ASCO 2022 Treatment Patterns and Real-World Effectiveness of Rituxim…

ASCO 2022 Conference Coverage

M. Di

99 views

ASCO 2022 Three-Year Follow-Up of Outcomes With KTE-X19 in R/R Mantl…

ASCO 2022 Conference Coverage

M. Wang

92 views

Lecture Summary - ASCO 2022 Three-Year Follow-Up of Outcomes With KT…

ASCO 2022 Conference Coverage

M. Wang

33 views

ASCO 2022 Brexucabtagene Autoleucel for R/R Mantle Cell Lymphoma: Re…

ASCO 2022 Conference Coverage

P. Jain

87 views

Lecture Summary - ASCO 2022 Brexucabtagene Autoleucel for R/R Mantle…

ASCO 2022 Conference Coverage

P. Jain

13 views

ASCO 2022 on the Initial Safety Run-in Results of the Phase III POLA…

ASCO 2022 Conference Coverage

M. Matasar

76 views

ASCO 2022 Correlates of Common Concerns in Older Cancer Survivors of…

ASCO 2022 Conference Coverage

M. Loh

19 views

Lecture Summary - ASCO 2022 Real World Experience of Combined Treatm…

ASCO 2022 Conference Coverage

M. Kalac

18 views

ASCO 2022 Real World Experience of Combined Treatment With Romidepsi…

ASCO 2022 Conference Coverage

M. Kalac

16 views

Lecture Summary - ASCO 2022 Bendamustine Rituximab vs. Ibrutinib as …

ASCO 2022 Conference Coverage

J. Abeykoon

102 views

ASCO 2022 Bendamustine Rituximab vs. Ibrutinib as Primary Therapy fo…

ASCO 2022 Conference Coverage

J. Abeykoon

1.7K views

Lecture Summary - ASCO 2022 on Clinical & PROs in a Phase III, Rando…

ASCO 2022 Conference Coverage

J. Westin

24 views

ASCO 2022 on Clinical & PROs in a Phase III, Randomized, Open-Label …

ASCO 2022 Conference Coverage

J. Westin

58 views

ASCO 2022 on CRC-403: A Phase 1/2 Study of bbT369, A Dual Targeting …

ASCO 2022 Conference Coverage

F. Locke

52 views

Lecture Summary - ASCO 2022 Updated Interim Analysis of the Randomiz…

ASCO 2022 Conference Coverage

C. Lee Batlevi

19 views

ASCO 2022 Updated Interim Analysis of the Randomized Phase 1b/3 Stud…

ASCO 2022 Conference Coverage

C. Lee Batlevi

64 views

ASCO 2022 PACIFIC Trial Updates: Response Kinetics, Safety & Efficac…

ASCO 2022 Conference Coverage

R. Steiner

413 views